Peptimmune Inc., a wholly owned subsidiary of Genzyme, leased its headquarters on the third floor of The Richards Building, located at 64 Sidney St. in Cambridge, MA. Moving into 11,000 square feet of office/lab earlier this month, the biotech company will use its space to develop immunotherapies for treating autoimmune and allergic diseases.